Costs of illness and care in Parkinson's disease: an evaluation in six countries.
We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.
von Campenhausen
Sonja
S
Department of Neurology, Philipps University Marburg, Rudolf-Bultmann-Strasse 8, Marburg, Germany.
Winter
Yaroslav
Y
Rodrigues e Silva
Antonio
A
Sampaio
Christina
C
Ruzicka
Evzen
E
Barone
Paolo
P
Poewe
Werner
W
Guekht
Alla
A
Mateus
Céu
C
Pfeiffer
Karl-P
KP
Berger
Karin
K
Skoupa
Jana
J
Bötzel
Kai
K
Geiger-Gritsch
Sabine
S
Siebert
Uwe
U
Balzer-Geldsetzer
Monika
M
Oertel
Wolfgang H
WH
Dodel
Richard
R
Reese
Jens P
JP
D000553:Ambulatory Care / Q000191:economics*; D000978:Antiparkinson Agents / Q000191:economics* / Q000627:therapeutic use; D017281:Cost of Illness; D005060:Europe; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D008134:Long-Term Care / Q000191:economics*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy* / Q000191:economics*; D011795:Surveys and Questionnaires
D000978:Antiparkinson Agents